Metro Healthcare Bhd.
MMYX:METRO0.22
MYR
0.00
(0.00%)
Metro Healthcare Bhd.
MYX:METRO
(Bursa Malaysia)
Recent
price
0.22
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Metro Healthcare Berhad is a Malaysia-based healthcare services provider primarily engaged in the provision of obstetrics and gynaecology, assisted reproductive technology, and paediatric healthcare services. Founded in 2010 and headquartered in Petaling Jaya, Selangor, Malaysia, the company operates an integrated network of specialized maternity hospitals, ambulatory care centres, and fertility clinics across Peninsular Malaysia. The company operates through distinct clinical and healthcare service segments: Assisted Reproductive Technology (ART) and Fertility Services, which include in-vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), ovulation induction, cryopreservation of oocytes, sperm, and embryos, pre-implantation genetic testing (PGT), semen analysis, and surgical sperm retrieval procedures including testicular sperm aspiration (TESA) and testicular sperm extraction (TESE); Obstetrics and Gynaecology (O&G) Services, comprising comprehensive antenatal, perinatal, and postnatal care, 3D and 4D ultrasound fetal imaging, natural and Caesarean deliveries, gynaecological surgeries including minimally invasive laparoscopy, hysteroscopy, myomectomy, ovarian cystectomy, and hysterectomy, as well as family planning consultations, cervical cancer screening, and management of reproductive health disorders; Paediatric Healthcare Services, offering neonatal care, routine childhood immunisations, developmental assessments, and outpatient paediatric medical consultations; and Diagnostic and Clinical Support Services, providing clinical laboratory diagnostics, genetic screening, and in-house pharmacy dispensing. Metro Healthcare caters to domestic patients and international medical tourists across key metropolitan and regional hubs in Malaysia, including Selangor, Kuala Lumpur, Perak, and Johor. In recent major developments, Metro Healthcare completed its transition from the LEAP Market to the ACE Market of Bursa Malaysia in November 2024 via an initial public offering (IPO) to fund its strategic expansion initiatives. The company has directed capital proceeds toward expanding its geographical footprint through the development and acquisition of new ambulatory care and fertility centres across Peninsular Malaysia, upgrading medical and embryology laboratory technologies, expanding clinical genetic testing capabilities, and scaling medical tourism partnerships to capture regional reproductive healthcare demand.